Dermatology Clinical Trial Analysis

Summary

Global Markets Direct's "Dermatology Clinical Trials Analysis" is an essential source of data and information pertaining to product clinical trials being carried out by Dermatology manufacturers, globally. The report provides exhaustive information on each clinical investigation study with coverage detailed coverage on the pipeline products these trials are being carried out for.

Scope

• The report provides analysis and review of the key clinical trials being carried out globally and across key Dermatology market categories - Dermatology
• The report covers information on each product being clinically tested with detailed coverage on the pipeline product profile, the indication it's being investigated for etc.
• The report provides an in-depth analysis of the clinical trials with information on trial phase, trial 0status, trial acronym, purpose, inclusion and exclusion criteria, description, design, intervention, investigator information, primary and secondary end-points and trial results
• The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by Global Markets Direct's team of industry experts.

Reasons to Buy

• Effectively plan your Mergers and Acquisitions and partnership strategies by identifying companies with the most promising pipeline.
• Stay ahead of the information curve in the fast changing Dermatology market.
• Plan in-licensing and out-licensing opportunities through review of pipeline products and technologies.
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
• Proactively plan and execute your competitive strategies by identifying clinical trials status of the leading competitive products in pipeline.
• Stay ahead of competition by understanding the changing competitive landscape in specific geographies.

Contents

• 1 List of Tables
• 1.2 List of Figures
• 2 Dermatology Clinical Trials
  • 2.1 Dermatology Clinical Trial By Equipment Type
  • 2.2 Dermatology Clinical Trials By Trial Phase and Trial Status
  • 2.3 Dermatology Pipeline Products By Development Stage
  • 2.4 Dermatology Pipeline Products By Therapy Area
  • 2.5 Dermatology Pipeline Products By News Summary
  • 2.6 Dermatology Apsara Thermal Wand System
    • 2.6.1 TP-1013 Pilot 1: Application of the Apsara Thermal Wand System
  • 2.7 Dermatology Noveon laser
    • 2.7.1 Noveon Laser Treatment To Effect Bioburden Reduction Or Elimination In Diabetic Foot Ulcer: A Davice Performance Clinical Study
    • 2.7.2 Treating Onychomychosis
    • 2.7.3 Noveon Laser Treatment Of Onychomycosis: A Device Performance Clinical Study
  • 2.8 Dermatology Smartfil
    • 2.8.1 A Study On The Efficiency Of Dermal Filler Delivery System
  • 2.9 Dermatology JUVEDERM Ultra with lidocaine
    • 2.9.1 Safety and Effectiveness of JUVDERM Injectable Gel With Lidocaine
• 3 Recent Developments
  • 3.1 Product News
    • 3.1.1 Jun 08, 2009: Reveal Sciences Launches CareType Analysis System At IECSC Show In Las Vegas
    • 3.1.2 Jun 04, 2009: Aesthera Installs 1000th Photopneumatic System In US
    • 3.1.3 Apr 21, 2009: PhotoMedex Unveils New XTRAC Laser Post-Procedure Kit
    • 3.1.4 Apr 20, 2009: Lexington International To Publish Pivotal Clinical Data Of HairMax LaserComb For Hair Growth
    • 3.1.5 Mar 23, 2009: Therative Features ThermaClear Acne Clearing Device In Annual Tyra Banks Show est of BeautyPrize Giveaway
    • 3.1.6 Mar 16, 2009: Therative's ThermaClear Acne Clearing Device Is Now Available At ULTA Stores Nationwide
    • 3.1.7 Mar 05, 2009: Nomir Medical's Noveon Device Shows 76 Percent Response Rate For The Treatment Of Onychomycosis In The Clinical Trial
    • 3.1.8 Mar 05, 2009: Noveon Device Of Nomir Medical Gets 76 Percent Response Rate In Pivotal Trial For The Treatment Of Onychomycosis
    • 3.1.9 Feb 02, 2009: Therative Chooses Euro RSCG Worldwide PR To Showcase ThermaClear Acne Clearing Device
    • 3.1.10 Jan 08, 2009: USPTO Grants Second Patent To Nomir Medical Technologies On Core Noveon Technology
    • 3.1.11 Jan 07, 2009: Nomir Medical's Noveon Dual-Wavelength Device Gets Second FDA 510(k) Clearance
    • 3.1.12 Dec 08, 2008: Nomir Medical Presents Positive MRSA Resistance Reversal And Eradication Data For Its Noveon Dual-Wavelength Device In The Human Nares
    • 3.1.13 Nov 06, 2008: Nomir Medical Technologies Granted European Patent On Core Noveon Technology
    • 3.1.14 Oct 29, 2008: CLRS Technology Announces CLARO Receives FDA Clearance For Treatment Of Acne
    • 3.1.15 Sep 23, 2008: Syneron Medical Ltd Receives FDA Clearance For Versatile Matrix RF Fractional Ablative Applicator
  • 3.2 Product Approvals
    • 3.2.1 Jan 07, 2009: Nomir Medical's Noveon Dual-Wavelength Device Gets Second FDA 510(k) Clearance
    • 3.2.2 Oct 29, 2008: CLRS Technology Announces CLARO Receives FDA Clearance For Treatment Of Acne
    • 3.2.3 Sep 23, 2008: Syneron Medical Ltd Receives FDA Clearance For Versatile Matrix RF Fractional Ablative Applicator
  • 3.3 Clinical Trials
    • 3.3.1 Apr 20, 2009: Lexington International To Publish Pivotal Clinical Data Of HairMax LaserComb For Hair Growth
    • 3.3.2 Mar 05, 2009: Nomir Medical's Noveon Device Shows 76 Percent Response Rate For The Treatment Of Onychomycosis In The Clinical Trial
    • 3.3.3 Mar 05, 2009: Noveon Device Of Nomir Medical Gets 76 Percent Response Rate In Pivotal Trial For The Treatment Of Onychomycosis
    • 3.3.4 Dec 08, 2008: Nomir Medical Presents Positive MRSA Resistance Reversal And Eradication Data For Its Noveon Dual-Wavelength Device In The Human Nares
• 4 Appendix
  • 4.1 Methodology
    • 4.1.1 Coverage
    • 4.1.2 Secondary Research
    • 4.1.3 Primary Research
    • 4.1.4 Expert Panel Validation
  • 4.2 Contact Us
  • 4.3 About Global Markets Direct
  • 4.4 Disclaimer
• 1 List of Tables
  • Table 1: Dermatology Clinical Trial By Equipment Type
  • Table 2: Dermatology Clinical Trials By Trial Phase and Trial Status
  • Table 3: Dermatology Pipeline Products By Development Stage
  • Table 4: Dermatology Pipeline Products By Therapy Area
  • Table 5: Dermatology Pipeline Products By News Summary
  • Table 6: Apsara Thermal Wand System - TP-1013 Pilot 1: Application of the Apsara Thermal Wand System
  • Table 7: Noveon laser - Noveon Laser Treatment To Effect Bioburden Reduction Or Elimination In Diabetic Foot Ulcer: A Davice Performance Clinical Study
  • Table 8: Noveon laser - Treating Onychomychosis
  • Table 9: Noveon laser - Noveon Laser Treatment Of Onychomycosis: A Device Performance Clinical Study
  • Table 10: Smartfil - A Study On The Efficiency Of Dermal Filler Delivery System
  • Table 11: JUVEDERM Ultra with lidocaine - Safety and Effectiveness of JUVDERM Injectable Gel With Lidocaine
• 1.2 List of Figures
  • Figure 1: Global Markets Direct Methodology